Immunological Subgroups Predicting Efficacy of Elotuzumab in Multiple Myeloma Patients: Insights from the GMMG-HD6 Clinical Trial
Gigi Nu Hoang Quy Ton,Katharina Kriegsmann,Mohamed H. S. Awwad,Axel Benner,Uta Bertsch,Britta Besemer,Mathias Haenel,Roland Fenk,Jana Schlenzka,Markus Munder,Jan Duerig,Igor Wolfgang Blau,Stefanie Huhn,Dirk Hose,Anna Jauch,Andreas Neubauer,Niels Weinhold,Christof Scheid,Roland Schroers,Ivana von Metzler,Aneta Schieferdecker,Joerg Thomalla,Peter Reimer,Rolf Mahlberg,Ullrich Graeven,Stephan Kremers,Uwe Martens,Christian Kunz,Manfred Hensel,Andrea Seidel-Glaetzer,Katja Weisel,Hans Salwender,Carsten Mueller-Tidow,Marc S. Raab,Hartmut Goldschmidt,Elias K. Mai,Michael Hundemer BLOOD（2023）
Key words
International Myeloma Working Group
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper